These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21777742)

  • 1. High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes.
    Bonello L; Pansieri M; Mancini J; Bonello R; Maillard L; Barnay P; Rossi P; Ait-Mokhtar O; Jouve B; Collet F; Peyre JP; Wittenberg O; de Labriolle A; Camilleri E; Cheneau E; Cabassome E; Dignat-George F; Camoin-Jau L; Paganelli F
    J Am Coll Cardiol; 2011 Jul; 58(5):467-73. PubMed ID: 21777742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study.
    Montalescot G; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; ten Berg J; Widimsky P; Luo J; Miller DL; Goedicke J
    Am Heart J; 2011 Apr; 161(4):650-656.e1. PubMed ID: 21473962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel.
    Bonello L; Mancini J; Pansieri M; Maillard L; Rossi P; Collet F; Jouve B; Wittenberg O; Laine M; Michelet P; Bessereau J; Lemesle G; Dignat-George F; Paganelli F; Camoin-Jau L
    J Thromb Haemost; 2012 Oct; 10(10):1999-2005. PubMed ID: 22863374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prasugrel as antiplatelet therapy in patients with acute coronary syndromes or undergoing percutaneous coronary intervention.
    Fletcher B; Thalinger KK
    Crit Care Nurse; 2010 Oct; 30(5):45-54. PubMed ID: 20889512
    [No Abstract]   [Full Text] [Related]  

  • 5. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual platelet reactivity, bleedings, and adherence to treatment in patients having coronary stent implantation treated with prasugrel.
    Parodi G; Bellandi B; Venditti F; Carrabba N; Valenti R; Migliorini A; Grassellini S; Ramazzotti E; Antoniucci D
    Am J Cardiol; 2012 Jan; 109(2):214-8. PubMed ID: 21996146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and prospects of antiplatelet therapy in percutaneous coronary intervention in Japan: focus on adenosine diphosphate receptor inhibitors.
    Ogawa H; Hokimoto S; Kaikita K; Yamamoto K; Chitose T; Ono T; Tsujita K
    J Cardiol; 2011 Jul; 58(1):6-17. PubMed ID: 21530174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes.
    Baker WL; White CM
    Am J Cardiovasc Drugs; 2009; 9(4):213-29. PubMed ID: 19655817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised study.
    Laine M; Frère C; Toesca R; Berbis J; Barnay P; Pansieri M; Michelet P; Bessereau J; Camilleri E; Ronsin O; Helal O; Paganelli F; Dignat-George F; Bonello L
    Thromb Haemost; 2014 Feb; 111(2):273-8. PubMed ID: 24154787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function monitoring in elderly patients on prasugrel after stenting for an acute coronary syndrome: design of the randomized antarctic study.
    Cayla G; Cuisset T; Silvain J; Henry P; Leclercq F; Carrié D; Etienne CS; Belle L; Rangé G; Pouillot C; Varenne O; Van Belle E; Boueri Z; Motreff P; Elhadad S; Delarche N; El Mahmoud R; Vicaut E; Collet JP; Montalescot G;
    Am Heart J; 2014 Nov; 168(5):674-81. PubMed ID: 25440795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prasugrel offers consistent platelet control in appropriate patients requiring treatment.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(2):107, 109. PubMed ID: 21556460
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
    Silber S; Helms TM; Garlichs C; Arntz HR; Weil J; Ince H; Klingenheben T; Hoffmann S; Boudriot E; Steiger H; Zugck C
    Dtsch Med Wochenschr; 2011 Apr; 136(15):782-5. PubMed ID: 21432747
    [No Abstract]   [Full Text] [Related]  

  • 14. Residual platelet reactivity and outcomes with 5 mg prasugrel therapy in elderly patients undergoing percutaneous coronary intervention.
    Parodi G; Bellandi B; Comito V; Capodanno D; Valenti R; Marcucci R; Carrabba N; Migliorini A; Gensini GF; Abbate R; Antoniucci D
    Int J Cardiol; 2014 Oct; 176(3):874-7. PubMed ID: 25139323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
    Thomas D; Giugliano RP
    Crit Pathw Cardiol; 2009 Mar; 8(1):12-9. PubMed ID: 19258833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.
    Michelson AD; Frelinger AL; Braunwald E; Downey WE; Angiolillo DJ; Xenopoulos NP; Jakubowski JA; Li Y; Murphy SA; Qin J; McCabe CH; Antman EM; Wiviott SD;
    Eur Heart J; 2009 Jul; 30(14):1753-63. PubMed ID: 19435740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prasugrel monitoring and bleeding in real world patients.
    Cayla G; Cuisset T; Silvain J; O'Connor SA; Kerneis M; Castelli C; Quilici J; Bonnet JL; Alessi MC; Morange PE; Collet JP; Montalescot G
    Am J Cardiol; 2013 Jan; 111(1):38-44. PubMed ID: 23040597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction.
    Perl L; Lerman-Shivek H; Rechavia E; Vaduganathan M; Leshem-Lev D; Zemer-Wassercug N; Dadush O; Codner P; Bental T; Battler A; Kornowski R; Lev EI
    J Am Coll Cardiol; 2014 Feb; 63(6):513-7. PubMed ID: 24148715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.